This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Finding a travel credit card with no annual fee can be rewarding. Learn what features matter most to maximize your travel benefits.
19,690 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A surge of optimism surrounds NVIDIA's latest driverless advances and what they mean for Uber stock investors. This p...
When energy costs rise, the economy can slow in surprising ways. This guide explains the link between rising prices a...
TRX Gold aims to outpace the market through Buckreef’s expansion and higher gold prices. This guide breaks down the k...
Bitcoin is acting as a fast-price detector for geopolitical risk, with intraday moves tied to crisis headlines rather...
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Tech shares wobble as regulatory headlines hit the tape. This piece breaks down the Snap slump, regulatory risks from...
A Crinetics director sells 5,000 shares as the stock dips. This guide breaks down what insider moves really mean for ...
As 2026 unfolds, investors are watching novavax (nvax) 2026 earnings for clarity on demand, pipeline milestones, and ...
Two-thirds of the S&P 500 have reported, and the results are surprisingly strong. This could mean smoother gains for ...
Pinterest sparked a noticeable stock move after its Q1 results, but a single quarter rarely writes the full comeback ...
As the 10-year yield hovers near 4.4%, many investors chase top-yield REITs for income. The real cost chasing reit be...